Here are six key points:
1. Ortho Kinematics may now sell the VMA in Canada.
2. The company already sells its device in the U.S. and European markets.
3. The VMA is a diagnostic test that assesses spinal motion and radiographic instability.
4. The test is designed to offer enhanced detection of radiographic instability, without losing any specificity.
5. The device also uses a lower dose of radiation compared to standard tests.
6. Ortho Kinematics plans to begin selling the VMA to Canadian spine care institutions later in 2016.
More articles on devices:
Wells Fargo ups Mazor Robotics’ stock rating to ‘outperform’: 3 notes
Mainstay Medical’s ReActiv8 receives CE Mark: 3 points
SeaSpine’s net loss reaches $12M; US spinal hardware revenue down 9.7% in Q1 2016: 9 takeaways
